+
データを開く
-
基本情報
登録情報 | データベース: PDB / ID: 1n4m | ||||||
---|---|---|---|---|---|---|---|
タイトル | Structure of Rb tumor suppressor bound to the transactivation domain of E2F-2 | ||||||
![]() |
| ||||||
![]() | CELL CYCLE / PROTEIN-PEPTIDE COMPLEX | ||||||
機能・相同性 | ![]() Defective translocation of RB1 mutants to the nucleus / enucleate erythrocyte differentiation / Rb-E2F complex / regulation of lipid kinase activity / positive regulation of collagen fibril organization / lens fiber cell apoptotic process / negative regulation of myofibroblast differentiation / maintenance of mitotic sister chromatid cohesion / cell morphogenesis involved in neuron differentiation / negative regulation of sprouting angiogenesis ...Defective translocation of RB1 mutants to the nucleus / enucleate erythrocyte differentiation / Rb-E2F complex / regulation of lipid kinase activity / positive regulation of collagen fibril organization / lens fiber cell apoptotic process / negative regulation of myofibroblast differentiation / maintenance of mitotic sister chromatid cohesion / cell morphogenesis involved in neuron differentiation / negative regulation of sprouting angiogenesis / chromatin lock complex / sister chromatid biorientation / importin-alpha family protein binding / positive regulation of transcription regulatory region DNA binding / Aberrant regulation of mitotic exit in cancer due to RB1 defects / positive regulation of extracellular matrix organization / Inhibition of replication initiation of damaged DNA by RB1/E2F1 / regulation of centromere complex assembly / positive regulation of macrophage differentiation / glial cell apoptotic process / tissue homeostasis / protein localization to chromosome, centromeric region / positive regulation of mitotic metaphase/anaphase transition / negative regulation of hepatocyte apoptotic process / neuron maturation / myoblast differentiation / digestive tract development / aortic valve morphogenesis / Replication of the SARS-CoV-1 genome / SWI/SNF complex / negative regulation of cold-induced thermogenesis / negative regulation of glial cell proliferation / Formation of Senescence-Associated Heterochromatin Foci (SAHF) / smoothened signaling pathway / negative regulation of G1/S transition of mitotic cell cycle / hepatocyte apoptotic process / Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes / RUNX2 regulates osteoblast differentiation / Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) / skeletal muscle cell differentiation / intrinsic apoptotic signaling pathway by p53 class mediator / negative regulation of apoptotic signaling pathway / negative regulation of cell cycle / chromosome organization / chondrocyte differentiation / glial cell proliferation / Cyclin E associated events during G1/S transition / Cyclin A:Cdk2-associated events at S phase entry / cis-regulatory region sequence-specific DNA binding / Nuclear events stimulated by ALK signaling in cancer / striated muscle cell differentiation / regulation of mitotic cell cycle / Condensation of Prophase Chromosomes / epithelial cell proliferation / negative regulation of protein kinase activity / RNA polymerase II transcription regulatory region sequence-specific DNA binding / negative regulation of smoothened signaling pathway / negative regulation of DNA-binding transcription factor activity / phosphoprotein binding / transcription initiation at RNA polymerase II promoter / APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 / negative regulation of cell growth / PML body / Oncogene Induced Senescence / spindle / negative regulation of inflammatory response / kinase binding / G1/S transition of mitotic cell cycle / RNA polymerase II transcription regulator complex / cellular response to insulin stimulus / negative regulation of epithelial cell proliferation / neuron projection development / transcription corepressor activity / Cyclin D associated events in G1 / sequence-specific double-stranded DNA binding / disordered domain specific binding / heterochromatin formation / cellular response to xenobiotic stimulus / MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis / Replication of the SARS-CoV-2 genome / DNA-binding transcription activator activity, RNA polymerase II-specific / Oxidative Stress Induced Senescence / neuron apoptotic process / DNA-binding transcription factor binding / spermatogenesis / molecular adaptor activity / RNA polymerase II-specific DNA-binding transcription factor binding / sequence-specific DNA binding / transcription by RNA polymerase II / Ras protein signal transduction / cell differentiation / DNA-binding transcription factor activity, RNA polymerase II-specific / regulation of cell cycle / protein dimerization activity / chromatin remodeling / RNA polymerase II cis-regulatory region sequence-specific DNA binding / DNA-binding transcription factor activity / cell division / negative regulation of gene expression / negative regulation of DNA-templated transcription 類似検索 - 分子機能 | ||||||
生物種 | ![]() | ||||||
手法 | ![]() ![]() ![]() | ||||||
![]() | Lee, C. / Chang, J.H. / Lee, H.S. / Cho, Y. | ||||||
![]() | ![]() タイトル: Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor 著者: Lee, C. / Chang, J.H. / Lee, H.S. / Cho, Y. | ||||||
履歴 |
|
-
構造の表示
構造ビューア | 分子: ![]() ![]() |
---|
-
ダウンロードとリンク
-
ダウンロード
PDBx/mmCIF形式 | ![]() | 161 KB | 表示 | ![]() |
---|---|---|---|---|
PDB形式 | ![]() | 127.9 KB | 表示 | ![]() |
PDBx/mmJSON形式 | ![]() | ツリー表示 | ![]() | |
その他 | ![]() |
-検証レポート
アーカイブディレクトリ | ![]() ![]() | HTTPS FTP |
---|
-関連構造データ
-
リンク
-
集合体
登録構造単位 | ![]()
| ||||||||
---|---|---|---|---|---|---|---|---|---|
1 | ![]()
| ||||||||
2 | ![]()
| ||||||||
3 | ![]()
| ||||||||
4 | ![]()
| ||||||||
単位格子 |
|
-
要素
#1: タンパク質 | 分子量: 40344.926 Da / 分子数: 2 / 断片: Residues 380-785 / 由来タイプ: 組換発現 / 由来: (組換発現) ![]() ![]() ![]() #2: タンパク質・ペプチド | 分子量: 2015.094 Da / 分子数: 3 / 断片: Residues 410-427 / 由来タイプ: 合成 詳細: The peptide was chemically synthesized. The sequence of the peptide is naturally found in Homo Sapiens (human). 参照: UniProt: Q14209 #3: 水 | ChemComp-HOH / | |
---|
-実験情報
-実験
実験 | 手法: ![]() |
---|
-
試料調製
結晶 | マシュー密度: 2.57 Å3/Da / 溶媒含有率: 52.06 % | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
結晶化 | 温度: 277 K / 手法: 蒸気拡散法, ハンギングドロップ法 / pH: 5.5 詳細: Ammonium sulfate Citrate, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K | |||||||||||||||||||||||||||||||||||||||||||||||||
結晶化 | *PLUS 温度: 4 ℃ / pH: 7.5 | |||||||||||||||||||||||||||||||||||||||||||||||||
溶液の組成 | *PLUS
|
-データ収集
放射光源 | 由来: ![]() ![]() |
---|---|
検出器 | タイプ: MACSCIENCE / 検出器: IMAGE PLATE / 日付: 2002年6月2日 |
放射 | プロトコル: SINGLE WAVELENGTH / 単色(M)・ラウエ(L): M / 散乱光タイプ: x-ray |
放射波長 | 波長: 1.12714 Å / 相対比: 1 |
反射 | 解像度: 2.2→50 Å / Num. obs: 37599 / Observed criterion σ(I): 1 / Biso Wilson estimate: 4.8 Å2 |
反射 | *PLUS 最低解像度: 50 Å / % possible obs: 86.3 % / Num. measured all: 93798 / Rmerge(I) obs: 0.082 |
反射 シェル | *PLUS 最高解像度: 2.2 Å / 最低解像度: 2.28 Å / % possible obs: 70.3 % / Rmerge(I) obs: 0.237 |
-
解析
ソフトウェア |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
精密化 | 構造決定の手法: ![]()
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | 溶媒モデル: FLAT MODEL / Bsol: 45.9332 Å2 / ksol: 0.390844 e/Å3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | Biso mean: 25.4 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refine analyze |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化ステップ | サイクル: LAST / 解像度: 2.2→19.65 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LS精密化 シェル | 解像度: 2.2→2.34 Å / Rfactor Rfree error: 0.021 / Total num. of bins used: 6
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Xplor file |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
精密化 | *PLUS 最高解像度: 2.2 Å / 最低解像度: 20 Å / % reflection Rfree: 5 % / Rfactor Rfree: 0.286 / Rfactor Rwork: 0.224 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
溶媒の処理 | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
原子変位パラメータ | *PLUS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
拘束条件 | *PLUS
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LS精密化 シェル | *PLUS 最低解像度: 2.28 Å / Rfactor Rfree: 0.328 / Rfactor Rwork: 0.287 |